CYP17A1 and breast carcinoma: Moreover, genetic analyses showed that the BRCA1 founder mutations and polymorphism in P450 1A1 and CYP17 might increase risk among Greenlandic women (166) A study in southern Quebec found an association between increased levels of PCBs, particularly PCB105, PCB118 and PCB156, and breast cancer (167).